Madrigal Pharmaceuticals
MDGL
$215.95
Share price
5.21%
Change (1 day)
-26.28%
Change (1 year)
Categories
Earnings for Madrigal Pharmaceuticals (MDGL)
Earnings in 2023 (TTM): -$0.37 B
According to Madrigal Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$0.37 B. a decrease over its 2022 earnings that were of -$0.3 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Madrigal Pharmaceuticals from 2007 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | -$0.37 B | 23.86% |
| 2022 | -$0.3 B | 20.24% |
| 2021 | -$0.25 B | 17.25% |
| 2020 | -$0.21 B | 117.61% |
| 2019 | -$94.98 M | 189.45% |
| 2018 | -$32.82 M | 3.85% |
| 2017 | -$31.6 M | 25.71% |
| 2016 | -$25.14 M | -50.81% |
| 2015 | -$51.1 M | -39.14% |
| 2014 | -$83.96 M | -4.12% |
| 2013 | -$87.56 M | |
| 2011 | -$45.44 M | 23.13% |
| 2010 | -$36.9 M | -145.81% |
| 2009 | $80.54 M | -185.95% |
| 2008 | -$93.71 M | 41.52% |
| 2007 | -$66.22 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -$0.19 B | -48.93% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -$18.95 M | -94.75% | 🇺🇸 USA |